Displaying all 3 publications

Abstract:
Sort:
  1. Omar MH, Mashita MK, Lim PS, Jamil MA
    J Steroid Biochem Mol Biol, 2005 Dec;97(5):421-5.
    PMID: 16293412
    To determine whether therapy with dydrogesterone in threatened abortion during the first trimester of pregnancy will improve pregnancy outcome.
    Matched MeSH terms: Dydrogesterone/therapeutic use*
  2. Pandian RU
    Maturitas, 2009 Dec;65 Suppl 1:S47-50.
    PMID: 20005647 DOI: 10.1016/j.maturitas.2009.11.016
    Threatened miscarriage is a common problem during pregnancy.
    Matched MeSH terms: Dydrogesterone/therapeutic use*
  3. Zainul Rashid MR, Lim JF, Nawawi NH, Luqman M, Zolkeplai MF, Rangkuty HS, et al.
    Gynecol Endocrinol, 2014 Mar;30(3):217-20.
    PMID: 24552449 DOI: 10.3109/09513590.2013.860960
    Gestational hypertension (GH) remains one of the main causes of high maternal and perinatal morbidity and mortality worldwide with the highest incidence among primigravidae of about 10%-15%. However, it was noted that the incidence of GH in primigravidae who conceived following assisted reproductive technique (ART) or intrauterine insemination (IUI) supplemented with dydrogesterone during the first trimester was low.

    Study site: Obstetrics and Gynecology
    Department, Pusat Perubatan Universiti Kebangsaan Malaysia PPUKM
    Matched MeSH terms: Dydrogesterone/therapeutic use*
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links